Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serosurvey for Japanese encephalitis virus antibodies following an outbreak in an immunologically naïve population, Victoria, 2022: a cross-sectional study.
Marsland MJ, Thomson TN, O'Brien HM, Peach E, Bellette J, Humphreys N, McKeon CA, Cross W, Moso MA, Batty M, Nicholson S, Karapanagiotidis T, Lim CK, Williamson DA, Winkler N, Koirala A, Macartney K, Glynn-Robinson A, Stewart T, Minko C, Snow KJ, Black J, Friedman ND. Marsland MJ, et al. Med J Aust. 2024 Jun 17;220(11):566-572. doi: 10.5694/mja2.52344. Epub 2024 May 27. Med J Aust. 2024. PMID: 38803004
Seroprevalence of Japanese encephalitis virus-specific antibodies in Australia following novel epidemic spread: protocol for a national cross-sectional study.
Winkler NE, Koirala A, Kaur G, Prasad S, Hirani R, Baker J, Hoad V, Gosbell IB, Irving DO, Hueston L, O'Sullivan MV, Kok J, Dwyer DE, Macartney K; Australian Japanese Encephalitis Virus Serosurvey Group; Australian Japanese encephalitis virus serosurvey group. Winkler NE, et al. BMJ Open. 2024 Feb 7;14(2):e075569. doi: 10.1136/bmjopen-2023-075569. BMJ Open. 2024. PMID: 38326269 Free PMC article.
Laboratory evaluation of ELISA and indirect immunofluorescence assay in response to emergence of Japanese encephalitis virus genotype IV in Australia.
Kinsella P, Moso M, Martin G, Karapangiotidis T, Karamalakis D, Nicholson S, Batty M, Jackson K, Marsland M, Thomson T, Manoharan L, O'brien H, Friedman ND, Bond K, Williamson DA, Lim CK. Kinsella P, et al. Among authors: marsland m. J Clin Virol. 2023 Nov;168:105580. doi: 10.1016/j.jcv.2023.105580. Epub 2023 Sep 9. J Clin Virol. 2023. PMID: 37717487 Free article.
Targeting XBP1 mRNA splicing sensitizes glioblastoma to chemotherapy.
Dowdell A, Marsland M, Faulkner S, Gedye C, Lynam J, Griffin CP, Marsland J, Jiang CC, Hondermarck H. Dowdell A, et al. Among authors: marsland m. FASEB Bioadv. 2023 Mar 13;5(5):211-220. doi: 10.1096/fba.2022-00141. eCollection 2023 May. FASEB Bioadv. 2023. PMID: 37151848 Free PMC article.
Japanese encephalitis: A rapid review of reported prevalence of infection, clinical disease and sequelae in immunologically naive populations to inform Australia's response.
Thomson TN, Marsland MJ, Minko C, Snow KJ, Friedman ND. Thomson TN, et al. Among authors: marsland mj. Aust N Z J Public Health. 2023 Apr;47(2):100041. doi: 10.1016/j.anzjph.2023.100041. Epub 2023 Apr 4. Aust N Z J Public Health. 2023. PMID: 37024425 Free article. Review. No abstract available.
ProNGF Expression and Targeting in Glioblastoma Multiforme.
Marsland M, Dowdell A, Faulkner S, Jobling P, Rush RA, Gedye C, Lynam J, Griffin CP, Baker M, Marsland J, Jiang CC, Hondermarck H. Marsland M, et al. Int J Mol Sci. 2023 Jan 13;24(2):1616. doi: 10.3390/ijms24021616. Int J Mol Sci. 2023. PMID: 36675126 Free PMC article.
17 results